Like pls_老虎社区_美港股上老虎

2021-06-08

Like pls

Why Bionano Genomics Stock Soared on Monday<blockquote>为什么Bionano Genomics股价周一飙升</blockquote>

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":117201559,"tweetId":"117201559","gmtCreate":1623141243371,"gmtModify":1634036513277,"author":{"id":3574909344077682,"idStr":"3574909344077682","authorId":3574909344077682,"authorIdStr":"3574909344077682","name":"chowchoww","avatar":"https://static.tigerbbs.com/273e81063110370ec027e4541d9ce720","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":3,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body>Like pls</body></html>","htmlText":"<html><head></head><body>Like pls</body></html>","text":"Like pls","highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/117201559","repostId":1151090475,"repostType":4,"repost":{"id":"1151090475","kind":"news","pubTimestamp":1623140703,"share":"https://www.laohu8.com/m/news/1151090475?lang=zh_CN&edition=full","pubTime":"2021-06-08 16:25","market":"us","language":"en","title":"Why Bionano Genomics Stock Soared on Monday<blockquote>为什么Bionano Genomics股价周一飙升</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1151090475","media":"Motley Fool","summary":"The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Gen","content":"The genetic testing specialist is bolstering its leadership ranks.What happened<blockquote>这家基因检测专家正在加强其领导层。发生了什么</blockquote>Shares of&nbsp;Bionano Genomics&nbsp;(NASDAQ:BNGO)&nbsp;surged 22% on Monday after the genome analysis company announced the hiring of a new chief commercial officer.<blockquote>本公司之股份生物纳米基因组学（纳斯达克：BNGO）周一飙升22%，此前这家基因组分析公司宣布聘请新的首席商务官。</blockquote>So what<blockquote>那又怎样</blockquote>Jason Priar will head up Bionano's sales teams and spearhead its revenue growth initiatives. He will be charged with striking deals with insurance companies and other third-party payers.<blockquote>Jason Priar将领导Bionano的销售团队并领导其收入增长计划。他将被指控与保险公司和其他第三方付款人达成交易。</blockquote>Priar previously served in healthcare-related sales and leadership positions at businesses including Forest Laboratories, PerkinElmer Genomics, and genetic testing specialist GeneDx. Notably, Priar helped GeneDx's sales rise from $8 million to more than $225 million during his time at the company.<blockquote>Priar此前曾在Forest Laboratories、PerkinElmer Genomics和基因检测专家GeneDx等企业担任医疗保健相关销售和领导职务。值得注意的是，Priar在公司任职期间帮助GeneDx的销售额从800万美元增长到超过2.25亿美元。</blockquote>\"Jason's intimate familiarity with the needs of traditional cytogenomics laboratories performing genome analysis in cancer and genetic diseases, combined with his understanding of needs of the physicians and pharmaceutical partners who apply the data, is among the best I have encountered in the industry,\" Bionano CEO Erik Holmlin said in a press release. \"I believe adding Jason to an already stellar team can have a profound impact on Bionano.\"<blockquote>Bionano首席执行官Erik Holmlin在一份新闻稿中表示：“Jason对在癌症和遗传疾病中进行基因组分析的传统细胞基因组学实验室的需求非常熟悉，再加上他对应用数据的医生和制药合作伙伴的需求的了解。“我相信将Jason加入一支已经很出色的团队可以对Bionano产生深远的影响。”</blockquote>Now what<blockquote>现在怎么办</blockquote>Mentions regarding Bionano have ramped up on Reddit's investing forums in recent days. Some traders appear to be attempting to create ashort squeezein the biotech's shares. This sharp increase in bullish chatter on social media sites likely also contributed to Bionano's gains on Monday.<blockquote>最近几天，Reddit投资论坛上对Bionano的提及越来越多。一些交易员似乎正试图对该生物技术公司的股票进行空头挤压。社交媒体网站上看涨言论的急剧增加可能也促成了Bionano周一的上涨。</blockquote>Yet Bionano is more than just a meme stock. Its Saphyr genome mapping system is earning strong reviews from healthcare researchers. Analysts, in turn, see plenty of upside for its shares. The consensus estimate calls for Bionano's stock to reach $12 in the next year -- or about 43% above its closing price on Monday.<blockquote>然而，Bionano不仅仅是一只模因股票。其Saphyr基因组图谱系统赢得了医疗保健研究人员的好评。反过来，分析师认为其股价还有很大的上涨空间。评级普遍预计Bionano股价明年将达到12美元，比周一收盘价高出约43%。</blockquote>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Bionano Genomics Stock Soared on Monday<blockquote>为什么Bionano Genomics股价周一飙升</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Bionano Genomics Stock Soared on Monday<blockquote>为什么Bionano Genomics股价周一飙升</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nMotley Fool2021-06-08 16:25\n\n</h4>\n</header>\n<article>\nThe genetic testing specialist is bolstering its leadership ranks.What happened<blockquote>这家基因检测专家正在加强其领导层。发生了什么</blockquote>Shares of&nbsp;Bionano Genomics&nbsp;(NASDAQ:BNGO)&nbsp;surged 22% on Monday after the genome analysis company announced the hiring of a new chief commercial officer.<blockquote>本公司之股份生物纳米基因组学（纳斯达克：BNGO）周一飙升22%，此前这家基因组分析公司宣布聘请新的首席商务官。</blockquote>So what<blockquote>那又怎样</blockquote>Jason Priar will head up Bionano's sales teams and spearhead its revenue growth initiatives. He will be charged with striking deals with insurance companies and other third-party payers.<blockquote>Jason Priar将领导Bionano的销售团队并领导其收入增长计划。他将被指控与保险公司和其他第三方付款人达成交易。</blockquote>Priar previously served in healthcare-related sales and leadership positions at businesses including Forest Laboratories, PerkinElmer Genomics, and genetic testing specialist GeneDx. Notably, Priar helped GeneDx's sales rise from $8 million to more than $225 million during his time at the company.<blockquote>Priar此前曾在Forest Laboratories、PerkinElmer Genomics和基因检测专家GeneDx等企业担任医疗保健相关销售和领导职务。值得注意的是，Priar在公司任职期间帮助GeneDx的销售额从800万美元增长到超过2.25亿美元。</blockquote>\"Jason's intimate familiarity with the needs of traditional cytogenomics laboratories performing genome analysis in cancer and genetic diseases, combined with his understanding of needs of the physicians and pharmaceutical partners who apply the data, is among the best I have encountered in the industry,\" Bionano CEO Erik Holmlin said in a press release. \"I believe adding Jason to an already stellar team can have a profound impact on Bionano.\"<blockquote>Bionano首席执行官Erik Holmlin在一份新闻稿中表示：“Jason对在癌症和遗传疾病中进行基因组分析的传统细胞基因组学实验室的需求非常熟悉，再加上他对应用数据的医生和制药合作伙伴的需求的了解。“我相信将Jason加入一支已经很出色的团队可以对Bionano产生深远的影响。”</blockquote>Now what<blockquote>现在怎么办</blockquote>Mentions regarding Bionano have ramped up on Reddit's investing forums in recent days. Some traders appear to be attempting to create ashort squeezein the biotech's shares. This sharp increase in bullish chatter on social media sites likely also contributed to Bionano's gains on Monday.<blockquote>最近几天，Reddit投资论坛上对Bionano的提及越来越多。一些交易员似乎正试图对该生物技术公司的股票进行空头挤压。社交媒体网站上看涨言论的急剧增加可能也促成了Bionano周一的上涨。</blockquote>Yet Bionano is more than just a meme stock. Its Saphyr genome mapping system is earning strong reviews from healthcare researchers. Analysts, in turn, see plenty of upside for its shares. The consensus estimate calls for Bionano's stock to reach $12 in the next year -- or about 43% above its closing price on Monday.<blockquote>然而，Bionano不仅仅是一只模因股票。其Saphyr基因组图谱系统赢得了医疗保健研究人员的好评。反过来，分析师认为其股价还有很大的上涨空间。评级普遍预计Bionano股价明年将达到12美元，比周一收盘价高出约43%。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/\">Motley Fool</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNGO":"Bionano Genomics"},"source_url":"https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1151090475","content_text":"The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Genomics (NASDAQ:BNGO) surged 22% on Monday after the genome analysis company announced the hiring of a new chief commercial officer.So whatJason Priar will head up Bionano's sales teams and spearhead its revenue growth initiatives. He will be charged with striking deals with insurance companies and other third-party payers.Priar previously served in healthcare-related sales and leadership positions at businesses including Forest Laboratories, PerkinElmer Genomics, and genetic testing specialist GeneDx. Notably, Priar helped GeneDx's sales rise from $8 million to more than $225 million during his time at the company.\"Jason's intimate familiarity with the needs of traditional cytogenomics laboratories performing genome analysis in cancer and genetic diseases, combined with his understanding of needs of the physicians and pharmaceutical partners who apply the data, is among the best I have encountered in the industry,\" Bionano CEO Erik Holmlin said in a press release. \"I believe adding Jason to an already stellar team can have a profound impact on Bionano.\"Now whatMentions regarding Bionano have ramped up on Reddit's investing forums in recent days. Some traders appear to be attempting to create ashort squeezein the biotech's shares. This sharp increase in bullish chatter on social media sites likely also contributed to Bionano's gains on Monday.Yet Bionano is more than just a meme stock. Its Saphyr genome mapping system is earning strong reviews from healthcare researchers. Analysts, in turn, see plenty of upside for its shares. The consensus estimate calls for Bionano's stock to reach $12 in the next year -- or about 43% above its closing price on Monday.","news_type":1,"symbols_score_info":{"BNGO":0.9}},"isVote":1,"tweetType":1,"viewCount":520,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":7,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/117201559"}